Regulators

Avexitide Phase 3 trial cuts post-bariatric hypoglycemia events by 55%

Small-Cell Lung Cancer Gets an ADC Signal With Teeth

Alzheimer’s Diagnosis Gets Another Gate

Progressive MS Still Needs Repair, Not Relapse Logic

Myeloma Gets an Accelerated Approval. The Endpoint Is the Politics.

Parkinson’s Gets Fast Track, Not Fast Proof

Anxiety Gets a Psychedelic Trial, Not a Shortcut

345 Salmonella Cases Later, The Supply Chain Is Still Being Reconstructed.

Antidepressant Trials Still Leave People Out
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
